Neyman J.Sur les applications de la théorie des probabilities aux experiences agaricales: essay des principle 1923. [English translation of excerpts by Dabrowska D, Speed T.]Stat Sci. 1990; 5:463-72.
2.
Fisher RADesign of Experiments. Edinburgh: Oliver and Boyd;1935.
3.
Orszag PRHealth costs are the real deficit threat. Wall Street Journal . 15 May 2009. Available from: http://online.wsj.com/article/SB124234365947221489.html
4.
Roy ADSome thoughts on the distribution of earnings. Oxford Econ Papers. 1951;3:135-46.
5.
Rubin D.Bayesian inference for causal effects: the role of randomization. Ann Stat. 1978;6:34-58.
6.
Stroup TS, McEvoy JP, Swartz MS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 2003;29(1):15-31.
7.
Munkin MK, Trivedi PKBayesian analysis of self-selection model with multiple outcomes using simulation-based estimation: an application to the demand for healthcare. J Econometrics. 2003;114:197-220.
Florens JP, Heckman JJ, Meghir C., Vytlacil E.Identification of treatment effects using control functions in models with continuous, endogenous treatment and heterogeneous effects. Econometrica. 2008;76(5):1191-206.
10.
Tunis SR, Stryer DB, Clancy CMPractical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. J Am Med Assoc. 203;290:1624-32.
Stinnett AA , Mullahy J.Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2 suppl):S65-80.
15.
Basu A., Meltzer D.Value of information on preference heterogeneity and individualized care. Med Decis Making. 2007;27(2): 112-27.
